Key stats
About NKGen Biotech, Inc.
Sector
Industry
CEO
Paul Song
Website
Headquarters
Santa Ana
FIGI
BBG0112YNVK3
NKGen Biotech, Inc. is a clinical-stage biotechnology company, which focuses on the development and commercialization of innovative autologous, allogeneic, and CAR-NK cell therapies utilizing a proprietary SNK platform. Its product candidates are based on a proprietary manufacturing and cryopreservation process which produces SNK cells that have high potency as defined by parameters such as cytotoxicity, cytokine production, and activating receptor expression. The company is headquartered in Santa Ana, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
